Michael Bian

Novartis Pharmaceuticals Australia New Zealand

Michael is an immunologist and currently works for Novartis Australia as national medical science liaison for dermatology.



E-Posters by Michael Bian
Secukinumab is superior to ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: CLARITY, a randomized, controlled, phase 3b trial
Secukinumab is superior to ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: CLARITY, a randomized, controlled, phase 3b trial
Continued treatment with secukinumab is associated with high retention or regain of response
Continued treatment with secukinumab is associated with high retention or regain of response